This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodríguez-Tudela, J. L.
Right arrow Articles by Gorgojo, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodríguez-Tudela, J. L.
Right arrow Articles by Gorgojo, B.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2000, p. 400-404, Vol. 44, No. 2
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Influence of Shaking on Antifungal Susceptibility Testing of Cryptococcus neoformans: a Comparison of the NCCLS Standard M27A Medium, Buffered Yeast Nitrogen Base, and RPMI-2% Glucose

Juan L. Rodríguez-Tudela,1,* Francisco Martín-Díez,1 Manuel Cuenca-Estrella,1 Laura Rodero,2 Yolanda Carpintero,1 and Begoña Gorgojo1

Servicio de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Ctra. Majadahonda-Pozuelo km.2, 28220 Majadahonda, Spain,1 and Departamento Micología, Instituto Nacional de Enfermedades Infecciosas, ANLIS "Dr. Carlos G. Malbrán," Avda. Velez Sarfield 563, 1281 Buenos Aires, Argentina2

Received 17 August 1999/Returned for modification 15 October 1999/Accepted 23 November 1999

Cryptococcus neoformans is a nonfermentative yeast that requires oxygen for growth. The shaking of culture media achieves good oxygenation, promoting the growth of cryptococci. In this study, three test media (RPMI 1640, RPMI 1640-2% glucose, and buffered yeast nitrogen base [BYNB]) recommended in the National Committee for Clinical Laboratory Standards M27A standard were examined. Growth abilities and minimum inhibitory concentrations (MICs) in microplates incubated at 35°C for 48 h were determined. The results indicated that shaking and an inoculum size of 105 CFU/ml yielded optimal growth of this yeast. Compared to RPMI 1640, supplementation of RPMI 1640 with 2% glucose did not significantly improve growth of C. neoformans and resulted in an 8.7-h delay of exponential growth. Cryptococcal growth in RPMI 1640 at 24 h was notably better than that in RPMI-2% glucose, although by 48 h the growths were comparable. The MIC range of amphotericin B observed for the C. neoformans strains grown in RPMI 1640 with or without glucose was too narrow to allow the separation of susceptible and resistant strains based on clinical outcome. The widest ranges of MICs of flucytosine and fluconazole were obtained with BYNB. This work demonstrates the need for a new antifungal susceptibility test for C. neoformans.


* Corresponding author. Mailing address: Servicio de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Ctra. Majadahonda-Pozuelo km.2, 28220 Majadahonda, Spain. Phone: 34 91 5097961. Fax: 34 91 5097966. E-mail: juanl.rodriguez-tudela{at}isciii.es.


Antimicrobial Agents and Chemotherapy, February 2000, p. 400-404, Vol. 44, No. 2
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Cuenca-Estrella, M., Gomez-Lopez, A., Gutierrez, M. O., Buitrago, M. J., Rodriguez-Tudela, J. L. (2008). Reliability of the WIDERYST Susceptibility Testing System for Detection of In Vitro Antifungal Resistance in Yeasts. Antimicrob. Agents Chemother. 52: 1062-1065 [Abstract] [Full Text]  
  • Cuenca-Estrella, M., Gomez-Lopez, A., Mellado, E., Buitrago, M. J., Monzon, A., Rodriguez-Tudela, J. L. (2006). Head-to-Head Comparison of the Activities of Currently Available Antifungal Agents against 3,378 Spanish Clinical Isolates of Yeasts and Filamentous Fungi. Antimicrob. Agents Chemother. 50: 917-921 [Abstract] [Full Text]  
  • Perkins, A., Gomez-Lopez, A., Mellado, E., Rodriguez-Tudela, J. L., Cuenca-Estrella, M. (2005). Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans. J Antimicrob Chemother 56: 1144-1147 [Abstract] [Full Text]  
  • Rodriguez-Tudela, J. L., Diaz-Guerra, T. M., Mellado, E., Cano, V., Tapia, C., Perkins, A., Gomez-Lopez, A., Rodero, L., Cuenca-Estrella, M. (2005). Susceptibility Patterns and Molecular Identification of Trichosporon Species. Antimicrob. Agents Chemother. 49: 4026-4034 [Abstract] [Full Text]  
  • Gomez-Lopez, A., Mellado, E., Rodriguez-Tudela, J. L., Cuenca-Estrella, M. (2005). Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review. J Antimicrob Chemother 55: 312-316 [Abstract] [Full Text]  
  • Cuenca-Estrella, M., Gomez-Lopez, A., Mellado, E., Garcia-Effron, G., Rodriguez-Tudela, J. L. (2004). In Vitro Activities of Ravuconazole and Four Other Antifungal Agents against Fluconazole-Resistant or -Susceptible Clinical Yeast Isolates. Antimicrob. Agents Chemother. 48: 3107-3111 [Abstract] [Full Text]  
  • Ramos, J. M., Cuenca-Estrella, M., Gutierrez, F., Elia, M., Rodriguez-Tudela, J. L. (2004). Clinical Case of Endocarditis due to Trichosporon inkin and Antifungal Susceptibility Profile of the Organism. J. Clin. Microbiol. 42: 2341-2344 [Abstract] [Full Text]  
  • Gadea, I., Cuenca-Estrella, M., Prieto, E., Diaz-Guerra, T. M., Garcia-Cia, J. I., Mellado, E., Tomas, J. F., Rodriguez-Tudela, J. L. (2004). Genotyping and Antifungal Susceptibility Profile of Dipodascus capitatus Isolates Causing Disseminated Infection in Seven Hematological Patients of a Tertiary Hospital. J. Clin. Microbiol. 42: 1832-1836 [Abstract] [Full Text]  
  • Rodero, L., Mellado, E., Rodriguez, A. C., Salve, A., Guelfand, L., Cahn, P., Cuenca-Estrella, M., Davel, G., Rodriguez-Tudela, J. L. (2003). G484S Amino Acid Substitution in Lanosterol 14-{alpha} Demethylase (ERG11) Is Related to Fluconazole Resistance in a Recurrent Cryptococcus neoformans Clinical Isolate. Antimicrob. Agents Chemother. 47: 3653-3656 [Abstract] [Full Text]  
  • Moore, C. B., Walls, C. M., Denning, D. W. (2003). Comparison of three methods for in vitro susceptibility testing of Candida species with flucytosine. J Antimicrob Chemother 51: 297-304 [Abstract] [Full Text]  
  • Brandt, M. E., Pfaller, M. A., Hajjeh, R. A., Hamill, R. J., Pappas, P. G., Reingold, A. L., Rimland, D., Warnock, D. W. (2001). Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrob. Agents Chemother. 45: 3065-3069 [Abstract] [Full Text]  
  • Rex, J. H., Pfaller, M. A., Walsh, T. J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M. A., Gosey, L. L., Odds, F. C., Rinaldi, M. G., Sheehan, D. J., Warnock, D. W. (2001). Antifungal Susceptibility Testing: Practical Aspects and Current Challenges. Clin. Microbiol. Rev. 14: 643-658 [Abstract] [Full Text]  
  • Meletiadis, J., Meis, J. F. G. M., Mouton, J. W., Verweij, P. E. (2001). Analysis of Growth Characteristics of Filamentous Fungi in Different Nutrient Media. J. Clin. Microbiol. 39: 478-484 [Abstract] [Full Text]  
  • Cuenca-Estrella, M., Díaz-Guerra, T. M., Mellado, E., Rodríguez-Tudela, J. L. (2001). Influence of Glucose Supplementation and Inoculum Size on Growth Kinetics and Antifungal Susceptibility Testing of Candida spp.. J. Clin. Microbiol. 39: 525-532 [Abstract] [Full Text]